Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Uveal Melanoma or Stage IV Uveal Melanoma AJCC v7
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial studies how well vorinostat works in treating patients with melanoma of the eye that has spread to other parts of the body (metastatic). Vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Provided treatments

  • Other: Laboratory Biomarker Analysis
  • Drug: Vorinostat
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01587352. The sponsor of the trial is National Cancer Institute (NCI) and it is looking for 40 volunteers for the current phase.
Official trial title:
A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma